PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
28-Apr-2026 LightForce Orthodontics Adds Metal Option to Its Generative Braces System Businesswire
28-Apr-2026 KA-EX Launches First Ready-to-Drink Creatine EAA+ Booster Businesswire
28-Apr-2026 Avenzo Therapeutics Advances the Combination of CDK4 Selective Inhibitor (AVZO-023) with CDK2 Selective Inhibitor (AVZO-021) in Ongoing Phase 1/2 ORION-1 Study in HR+/HER2- Breast Cancer Businesswire
28-Apr-2026 Neurable Open for Business: Scaling Neurotechnology Adoption Through Global OEM Integration Businesswire
28-Apr-2026 Orca Bio Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Orca-Q® for the Treatment of High-Risk Hematologic Malignancies Businesswire
28-Apr-2026 Sun Pharma signe un accord définitif pour acquérir Organon Businesswire
28-Apr-2026 Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors Businesswire
28-Apr-2026 Niagen Bioscience Adds Olympia Pharmaceuticals to 503B Compounding Partner Network for Niagen Plus™ Businesswire
28-Apr-2026 Thermo Fisher Scientific Opens U.S. Flagship Bioprocess Design Center to Accelerate the Delivery of Life-changing Therapies Businesswire
28-Apr-2026 Printing the Future of Oncology: CTIBIOTECH Invests €3M and Secures €1.25M from France 2030 to Revolutionize Personalized Cancer Care Businesswire
28-Apr-2026 Medtronic announces CE Mark for Stealth AXiS™ surgical system Medtronic
28-Apr-2026 University Hospitals Sussex cuts patient call wait times by 90% as AI supports call staff Netcall
28-Apr-2026 Mental health survey is opportunity for shaping more innovation-led support services for young people InnoScot Health
28-Apr-2026 Scottish universities can play ‘strong and unrelenting’ role in Healthier Communities 2030 commitment InnoScot Health
28-Apr-2026 Neurogene Announces Upcoming Presentation on the Therapeutic Rationale for ICV Delivery in CNS-Targeted Gene Therapy Businesswire
28-Apr-2026 Precision BioSciences Announces Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting Businesswire
28-Apr-2026 U.S. Food and Drug Administration Accepts New Drug Application for Zipalertinib for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations Businesswire
28-Apr-2026 Incyte Appoints Suketu (Suky) Upadhyay as Chief Financial Officer Businesswire
28-Apr-2026 Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher Businesswire
28-Apr-2026 CatalYm Appoints Christian S. Schade as Chairman of the Board of Directors Businesswire